Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Docetaxel and Cisplatin CCRT for Head and Neck Cancer
NCT01126008Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Nov 2009
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in head and neck cancer (HNC), sponsored by Samsung Medical Center. Started Nov 2009; status: completed.
02
Drugs
docetaxel
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT01126008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01126008.